Lipoxin A4 inhibits the development of endometriosis in mice: the role of anti-inflammation and anti-angiogenesis

Zhangye Xu, Xu Z, Feng Zhao, Zhao F, Lin F, Feng Lin, Chen J, Jinxia Chen, Ying‐Ping Huang, Yingping Huang, Huang Y
American journal of reproductive immunology (New York, N.Y. : 1989) · 2012 · vol. 67(6) , pp. 491–497 · doi:10.1111/j.1600-0897.2011.01101.x · PMID:22229383 · W1997465990
Lab / animal OA: closed CC0 ⤵ 30 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Lipoxin A4 treatment significantly inhibited endometriosis progression in mice by reducing lesion size, pro-inflammatory factors, MMP9 activity, and VEGF levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PROBLEM: To evaluate the effects of the anti-inflammatory and anti-angiogenic roles of LXA4 on endometriosis in mice. METHOD OF STUDY: Endometriosis was induced in 40 mice and separated into two groups. LXA4 group was administered by LXA4 for 3 weeks. The endometriotic lesions were counted, measured, and identified by pathology. The presence of a panel of pro-inflammatory factors was assessed by real-time RT-PCR, and enzyme-linked immunoassay, the mRNA, protein levels of matrix metalloproteinase (MMPs), and vascular endothelial growth factor (VEGF) were determined by real-time RT-PCR and immunohistochemistry; the activity of MMPs was evaluated by gelatin zymography. RESULTS: Treatment with LXA4 significantly inhibited endometriotic lesion development (13.58 ± 4.01 mm(2) in LXA4 group and 23.20 ± 7.49 mm(2) , P = 0.0002), downregulated pro-inflammatory factors, suppressed the activity of MMP9, and reduced the VEGF levels associated with endometriosis in mice. CONCLUSION: LXA4 may inhibit the progression of endometriosis possibly by anti-inflammation and anti-angiogenesis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Angiogenesis Inhibitors Anti-Inflammatory Agents, Non-Steroidal Endometriosis Lipoxins Angiogenesis Inhibitors Angiogenesis Inhibitors Angiogenesis Inhibitors Animals Animals Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Cytokines Cytokines Cytokines Cytokines Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

Cited by (30)

Source provenance

europepmc
last seen: 2026-10-25T06:09:34.811731+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:09:51.187616+00:00
unpaywall
last seen: 2026-10-24T06:30:43.844863+00:00
License: CC0 · commercial use OK